RedShift BioAnalytics Launches Aurora Platform

Designed to provide ultra-sensitive, ultra-precise measurements of the structure of biomolecules using MMS technology.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

RedShift BioAnalytics has launched Aurora, the company’s latest system using MMS technology. Aurora is designed to provide ultra-sensitive, ultra-precise measurements of the structure of biomolecules through a new technology called Microfluidic Modulation Spectroscopy (MMS), more rapidly, with less sample volume, and with improved software and analytics features. According to the compmay, Aurora delivers a 10-fold decrease in sample volume at a lower price point than the first generation M...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters